>
Trade Show

Meet Datwyler at
PODD Conference

De-Risking CCS Selection, Qualification, and Compatibility for Parenteral and Ophthalmic Applications

Meet Datwyler to discuss container closure strategies that support regulatory approval and reliable performance in parenteral and ophthalmic drug delivery. 
Date October 1, 2026 – October 1, 2026
Location The Sheraton Boston | Boston, MA, USA
Details Booth #406
Event Overview

De-Risking Packaging for Complex Drug Products

The Parenteral and Ophthalmic Drug Discussion (PODD) Conference is where CMC, regulatory, and packaging scientists convene for focused, high-value technical exchange on the most demanding drug delivery formats. At Booth #406, Datwyler presents our approach to container closure system selection for parenteral applications — including our extractables and leachables dataset, container closure integrity testing capabilities, and regulatory dossier support designed to accelerate your CMC documentation. For both injectable and ophthalmic drug products, our elastomer and closure portfolio provides the validated, de-risked packaging platform that helps your product move from development to approval with confidence. Visit Booth #406 to put your toughest packaging challenge to our team.

Solutions Spotlight

What We're Showcasing at PODD Conference

Explore the solutions and technologies most relevant to this event.

Drug Delivery Solutions for Home-Based & Patient-Centric Care
Featured Solution

Drug Delivery Solutions for Home-Based & Patient-Centric Care

As subcutaneous and at-home administration becomes the new standard, your packaging must keep pace. Datwyler offers reliable components compatible with biologics and GLP-1 formulations, including solutions for auto-injectors, prefillable syringe systems, and ready-to-use components designed for contamination-free fill-finish operations.
Container Closure Systems for Combination Products & Wearable Devices
Featured Solution

Container Closure Systems for Combination Products & Wearable Devices

Datwyler presents elastomer components and closure systems engineered for integration into auto-injectors, wearable devices, and on-body delivery platforms — offering device engineers and combination product developers the performance, compatibility, and regulatory confidence needed for subcutaneous and parenteral applications.
High-Performance Components for Biologic Drug Delivery
Featured Solution

High-Performance Components for Biologic Drug Delivery

Biologic therapies demand packaging components that deliver exceptional purity, compatibility, and performance. Datwyler's NeoFlex™ and OmniFlex® elastomer platforms are engineered to support sensitive biologic formulations, with ultra-clean manufacturing, optimized extractables profiles, and the reliability required for complex injectable drug products.
EVENT UPDATES

Stay informed on upcoming Datwyler events

Subscribe to receive updates on conferences, presentations, and opportunities to connect with our team.